Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vaccines"" wg kryterium: Temat


Tytuł :
Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases.
Autorzy :
Xu Z; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Ho M; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Bordoloi D; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Kudchodkar S; GeneOne Life Science Inc., Seoul, South Korea.
Khoshnejad M; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Giron L; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Zaidi F; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Jeong M; GeneOne Life Science Inc., Seoul, South Korea.
Roberts CC; GeneOne Life Science Inc., Seoul, South Korea.
Park YK; GeneOne Life Science Inc., Seoul, South Korea.
Maslow J; GeneOne Life Science Inc., Seoul, South Korea.
Abdel-Mohsen M; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Muthumani K; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA. .; GeneOne Life Science Inc., Seoul, South Korea. .
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2410, pp. 229-263.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Communicable Diseases, Emerging*/prevention & control
Vaccines, DNA*/immunology
Viral Vaccines*/genetics
Viral Vaccines*/immunology
Animals ; COVID-19 ; Humans ; Immunity ; SARS Virus ; SARS-CoV-2 ; Vaccines, Attenuated/immunology ; Vaccines, Inactivated/immunology ; Vaccines, Synthetic/immunology
Czasopismo naukowe
Tytuł :
Nucleic acid vaccines: A taboo broken and prospect for a hepatitis B virus cure.
Autorzy :
Tsounis EP; Division of Gastroenterology, Department of Internal Medicine, University of Patras, Patras 26504, Greece.
Mouzaki A; Division of Hematology, Department of Internal Medicine, University of Patras, Patras 26504, Greece.
Triantos C; Division of Gastroenterology, Department of Internal Medicine, University of Patras, Patras 26504, Greece. .
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Nov 07; Vol. 27 (41), pp. 7005-7013.
Typ publikacji :
Editorial
MeSH Terms :
Hepatitis B*/prevention & control
Hepatitis B, Chronic*/prevention & control
Vaccines, DNA*
Hepatitis B Surface Antigens ; Hepatitis B Vaccines ; Hepatitis B virus/genetics ; Humans ; Nucleic Acid-Based Vaccines ; Taboo
Opinia redakcyjna
Tytuł :
Recombinant Escherichia coli Cell Lysates as a Low-Cost Alternative for Vaccines Against Veterinary Clostridial Diseases.
Autorzy :
Moreira C Jr; Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Moreira GMSG; Institut fϋr Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr, Technische Universität Braunschweig, Braunschweig, Germany.
Donassolo RA; Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Ferreira MRA; Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Alves MLF; Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Rodrigues RR; Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Conceição FR; Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil. .
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2411, pp. 105-115.
Typ publikacji :
Journal Article
MeSH Terms :
Escherichia coli Infections*/prevention & control
Escherichia coli Infections*/veterinary
Escherichia coli Vaccines*
Animals ; Bacterial Vaccines ; Escherichia coli/genetics ; Escherichia coli/immunology ; Inclusion Bodies ; Mice ; Vaccines, Synthetic
Czasopismo naukowe
Tytuł :
De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
Autorzy :
Marinaki S; Department of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.
Kolovou K; Department of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.
Liapis G; Department of Pathology, Laiko Hospital, 11527 Athens, Greece.
Skalioti C; Department of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.
Tsiakas S; Department of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.
Boletis I; Department of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.
Pokaż więcej
Źródło :
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 Dec 27; Vol. 58 (1). Date of Electronic Publication: 2021 Dec 27.
Typ publikacji :
Case Reports
MeSH Terms :
COVID-19*
Kidney Transplantation*/adverse effects
Nephrosis, Lipoid*
Viral Vaccines*
BNT162 Vaccine ; COVID-19 Vaccines ; Female ; Humans ; SARS-CoV-2 ; Vaccination ; Vaccines, Synthetic ; mRNA Vaccines
Raport
Tytuł :
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021.
Autorzy :
Poukka E; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland. Electronic address: .
Baum U; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland. Electronic address: .
Palmu AA; Population Health Unit, Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Tampere, Finland.
Lehtonen TO; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Salo H; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Nohynek H; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Leino T; Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2022 Jan 31; Vol. 40 (5), pp. 701-705. Date of Electronic Publication: 2021 Dec 18.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
BNT162 Vaccine ; Cohort Studies ; Finland/epidemiology ; Health Personnel ; Humans ; SARS-CoV-2 ; Vaccine Efficacy ; Vaccines, Synthetic ; mRNA Vaccines
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
Autorzy :
Williams KV; Department of Family Medicine, University of Pittsburgh, 4420 Bayard Street, Suite 520, Pittsburgh, PA 15260, USA. Electronic address: .
Zhai B; Department of Immunology, University of Pittsburgh, 9127 Rangos Research Center, 4401 Penn Avenue, Pittsburgh, PA 15224 USA. Electronic address: .
Alcorn JF; Department of Immunology, University of Pittsburgh, 9127 Rangos Research Center, 4401 Penn Avenue, Pittsburgh, PA 15224 USA; Department of Pediatrics, University of Pittsburgh, 3520 Fifth Avenue, Pittsburgh, PA 15213, USA. Electronic address: .
Patricia Nowalk M; Department of Family Medicine, University of Pittsburgh, 4420 Bayard Street, Suite 520, Pittsburgh, PA 15260, USA. Electronic address: .
Levine MZ; National Center Immunizations and Respiratory Disease, Center for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Kim SS; National Center Immunizations and Respiratory Disease, Center for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Flannery B; National Center Immunizations and Respiratory Disease, Center for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Moehling Geffel K; Department of Family Medicine, University of Pittsburgh, 4420 Bayard Street, Suite 520, Pittsburgh, PA 15260, USA. Electronic address: .
Jaber Merranko A; Falk Pharmacy, University of Pittsburgh Medical Center (UPMC), 3601 Fifth Avenue, Pittsburgh, PA 15213, USA. Electronic address: .
Nagg JP; Department of Pediatrics, University of Pittsburgh, 3520 Fifth Avenue, Pittsburgh, PA 15213, USA. Electronic address: .
Collins M; Department of Family Medicine, University of Pittsburgh, 4420 Bayard Street, Suite 520, Pittsburgh, PA 15260, USA. Electronic address: .
Susick M; Department of Family Medicine, University of Pittsburgh, 4420 Bayard Street, Suite 520, Pittsburgh, PA 15260, USA. Electronic address: .
Clarke KS; Department of Family Medicine, University of Pittsburgh, 4420 Bayard Street, Suite 520, Pittsburgh, PA 15260, USA. Electronic address: .
Zimmerman RK; Department of Family Medicine, University of Pittsburgh, 4420 Bayard Street, Suite 520, Pittsburgh, PA 15260, USA. Electronic address: .
Martin JM; Department of Pediatrics, University of Pittsburgh, 3520 Fifth Avenue, Pittsburgh, PA 15213, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2022 Jan 31; Vol. 40 (5), pp. 780-788. Date of Electronic Publication: 2021 Dec 21.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/prevention & control
Adolescent ; Antibodies, Viral ; Antibody Formation ; Child ; Hemagglutination Inhibition Tests ; Humans ; Influenza A Virus, H3N2 Subtype ; Vaccines, Attenuated ; Vaccines, Inactivated ; Young Adult
Czasopismo naukowe
Tytuł :
A new self-attenuated therapeutic influenza vaccine that uses host cell-restricted attenuation by artificial microRNAs.
Autorzy :
Wen K; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.
Wang H; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA; Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, Guangdong 510182, China.
Chen Y; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.
Yang H; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA; Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, Guangdong 510182, China.
Zheng Z; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA; Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, Guangdong 510182, China.
Yan Y; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA; Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, Guangdong 510182, China.
Realivazquez Pena A; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA; Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.
Zeng M; Center of Emphasis in Infectious Diseases, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA; Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2022 Jan 25; Vol. 612, pp. 121325. Date of Electronic Publication: 2021 Dec 06.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza Vaccines*
Influenza, Human*/prevention & control
MicroRNAs*/genetics
Orthomyxoviridae Infections*/prevention & control
mRNA Vaccines*
Animals ; Antigenic Drift and Shift ; Humans ; Mice ; Vaccines, Attenuated
Czasopismo naukowe
Tytuł :
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Autorzy :
Katz MA; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; University of Michigan, School of Public Health, Ann Arbor, MI, USA.
Harlev EB; Schneider Children's Medical Center of Israel, Petach Tikvah, Israel.
Chazan B; Infectious Diseases and Infection Control Unit, Ha'Emek Medical Center, Afula, Israel; Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Chowers M; Infectious Diseases, Meir Medical Center, Kfar Saba, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Greenberg D; Pediatric Infectious Disease Unit the Pediatric Division, Soroka University Medical Center, Beer Sheva, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Peretz A; Occupational Medicine Clinic, Rabin Medical Center, Petah Tikva, Israel.
Tshori S; Research Authority, Kaplan Medical Center, Rehovot, Israel; The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Levy J; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
Yacobi M; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
Hirsch A; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
Amichay D; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel.
Weinberger R; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel.
Dor AB; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel.
Taraday EK; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel.
Reznik D; Schneider Children's Medical Center of Israel, Petach Tikvah, Israel.
Chayat CB; Multidisciplinary Laboratory, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel.
Sagas D; Clinical Microbiology Laboratory, Ha'Emek Medical Center, Afula, Israel.
Zvi HB; Microbiology Department, Rabin Medical Center, Petah Tikva, Israel.
Berdinstein R; The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Microbiology Department, Kaplan Medical Center, Rehovot, Israel.
Rashid G; Department of Clinical Laboratories, Meir Medical Center, Kfar Saba, Israel.
Avni YS; Virology, Soroka University Medical Center, Beer Sheva, Israel.
Mandelboim M; Central Virology Laboratory, Chaim Sheba Medical Center, Ministry of Health, Ramat Gan, Israel; Department of Epidemiology and Preventive Medicine, Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel.
Zuckerman N; Central Virology Laboratory, Chaim Sheba Medical Center, Ministry of Health, Ramat Gan, Israel.
Rainy N; Laboratory Division, Shamir Medical Center, Zerifin, Israel.
Akriv A; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
Dagan N; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; Software and Information Systems Engineering, Ben Gurion University, Beer Sheva, Israel; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA; Ivan and Francesca Berkowitz Family Living Laboratory at Harvard Medical School, Boston, MA, USA.
Kepten E; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
Barda N; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; Software and Information Systems Engineering, Ben Gurion University, Beer Sheva, Israel; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA; Ivan and Francesca Berkowitz Family Living Laboratory at Harvard Medical School, Boston, MA, USA.
Balicer RD; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2022 Jan 24; Vol. 40 (3), pp. 512-520. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
BNT162 Vaccine ; Delivery of Health Care ; Hospitals ; Humans ; Prospective Studies ; SARS-CoV-2 ; Vaccine Efficacy ; Vaccines, Synthetic ; mRNA Vaccines
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021.
Autorzy :
Kwok SL; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China.
Cheng SM; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.; HKU-Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China.; Centre for Immunology and Infection (C2i), Hong Kong Science Park, Hong Kong Special Administrative Region, China.
Leung JN; Hong Kong Red Cross Blood Transfusion Service, Hospital Authority, Hong Kong Special Administrative Region, China.
Leung K; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China.
Lee CK; Hong Kong Red Cross Blood Transfusion Service, Hospital Authority, Hong Kong Special Administrative Region, China.
Peiris JM; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.; HKU-Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China.; Centre for Immunology and Infection (C2i), Hong Kong Science Park, Hong Kong Special Administrative Region, China.
Wu JT; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China.
Pokaż więcej
Źródło :
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2022 Jan; Vol. 27 (2).
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
Antibodies, Viral ; Blood Donors ; Hong Kong ; Humans ; RNA, Messenger ; SARS-CoV-2 ; Vaccination ; Vaccines, Inactivated ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł :
Work Absence Following COVID-19 Vaccination in a Cohort of Healthcare Personnel.
Autorzy :
Breeher LE; Occupational Health Services, Practice Administration, Mayo Clinic, Rochester, Minnesota (Dr Breeher, Dr Tommaso, Hainy, Dr Swift), Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota (Dr Breeher, Dr Wolf, Dr Swift), Occupational Health Services, Mayo Clinic, Scottsdale, Arizona (Dr Geyer), Department of Hospital Internal Medicine, Mayo Clinic, Scottsdale, Arizona (Dr Geyer), Employee Health Services, Mayo Clinic, Jacksonville, Florida (Dr Brinker), Department of Family Medicine, Mayo Clinic, Jacksonville, Florida (Dr Brinker), Recovery and Claims Services, Mayo Clinic, Rochester, Minnesota (Kohlnhofer).
Wolf ME
Geyer H
Brinker T
Tommaso C
Kohlnhofer S
Hainy C
Swift M
Pokaż więcej
Źródło :
Journal of occupational and environmental medicine [J Occup Environ Med] 2022 Jan 01; Vol. 64 (1), pp. 6-9.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
Delivery of Health Care ; Health Personnel ; Humans ; SARS-CoV-2 ; Vaccination ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł :
mRNA Vaccines to Protect Against Diseases.
Autorzy :
Thomas S; Lankenau Institute for Medical Research, Wynnewood, PA, USA. .
Abraham A; Lankenau Institute for Medical Research, Wynnewood, PA, USA.
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2410, pp. 111-129.
Typ publikacji :
Journal Article
MeSH Terms :
Vaccine Development*
Viral Vaccines*/genetics
mRNA Vaccines*
COVID-19/prevention & control ; COVID-19 Vaccines ; Humans ; Liposomes ; Nanoparticles ; Spike Glycoprotein, Coronavirus
Czasopismo naukowe
Tytuł :
Spectrum of neurological complications following COVID-19 vaccination.
Autorzy :
Garg RK; Department of Neurology, King George Medical University, Lucknow, Uttar Pradesh, India, PIN-226003. .
Paliwal VK; Department of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareli road, Lucknow, India.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Jan; Vol. 43 (1), pp. 3-40. Date of Electronic Publication: 2021 Oct 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
Female ; Humans ; SARS-CoV-2 ; Vaccination/adverse effects ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł :
COVID-19 mRNA Vaccine-induced Pneumonitis.
Autorzy :
Matsuzaki S; Department of Respiratory Medicine, Tatebayashi Kosei General Hospital, Japan.
Kamiya H; Department of Respiratory Medicine, Tatebayashi Kosei General Hospital, Japan.
Inoshima I; Department of Respiratory Medicine, Tatebayashi Kosei General Hospital, Japan.
Hirasawa Y; Department of Pulmonology, International University of Health and Welfare, Japan.
Tago O; Department of Dermatology, Tatebayashi Kosei General Hospital, Japan.
Arai M; Department of Internal Medicine, Tatebayashi Kosei General Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jan 01; Vol. 61 (1), pp. 81-86. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
COVID-19*
COVID-19 Vaccines*
Aged ; BNT162 Vaccine ; Humans ; Male ; RNA, Messenger ; SARS-CoV-2 ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł :
Development of Nano-Conjugated DNA Vaccine Against Edwardsiellosis Disease in Fish.
Autorzy :
Bedekar MK; Department of Aquatic Animal Health, ICAR- Central Institute of Fisheries Education, Mumbai, India. .
Kole S; Department of Aquatic Animal Health, ICAR- Central Institute of Fisheries Education, Mumbai, India.; Department of Aqualife Medicine, Chonnam National University, Gwangju, Republic of Korea.
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2411, pp. 195-204.
Typ publikacji :
Journal Article
MeSH Terms :
Fish Diseases*/prevention & control
Vaccines, DNA*/genetics
Animals ; Bacterial Vaccines/genetics ; DNA ; Enterobacteriaceae Infections ; Fishes ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2.
Autorzy :
Liu Q; Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Ding Z; Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Lan J; Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Wong G; Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China. .; Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, QC, Canada. .
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2410, pp. 193-208.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/prevention & control
COVID-19 Vaccines*
Vaccines, Synthetic*
Ebolavirus/immunology ; Humans ; Pandemics ; Spike Glycoprotein, Coronavirus/genetics ; Vaccine Development ; Vaccines, Attenuated
Czasopismo naukowe
Tytuł :
Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals.
Autorzy :
Al-Sadeq DW; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
Shurrab FM; Biomedical Research Center, Qatar University, Doha 2713, Qatar.
Ismail A; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
Amanullah FH; Biomedical Research Center, Qatar University, Doha 2713, Qatar.
Thomas S; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biological and Environmental Sciences, College of Arts and Science, Qatar University, P.O. Box 2713, Doha, Qatar.
Aldewik N; Clinical and Metabolic Genetics Section, Pediatrics Department, Hamad General Hospital (HGH), Women's Wellness and Research Center (WWRC), Interim Translational Research Institute (iTRI), Hamad Medical Corporation (HMC), College of Health and Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar, P.O. Box 3050, Doha, Qatar.
Yassine HM; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
Abdul Rahim HF; College of Health Sciences, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
Abu-Raddad L; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.; Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, USA.
Nasrallah GK; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
Pokaż więcej
Źródło :
Journal of travel medicine [J Travel Med] 2021 Dec 29; Vol. 28 (8).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Vaccines*
2019-nCoV Vaccine mRNA-1273 ; Antibodies, Viral ; Antibody Formation ; BNT162 Vaccine ; COVID-19 Vaccines ; Humans ; Immunity ; SARS-CoV-2 ; mRNA Vaccines
Czasopismo naukowe
Tytuł :
The role of non-COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study.
Autorzy :
Jamieson KH; Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA 19104; .
Romer D; Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA 19104.
Jamieson PE; Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA 19104.
Winneg KM; Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA 19104.
Pasek J; Department of Communication and Media, University of Michigan, Ann Arbor, MI 48109.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Dec 28; Vol. 118 (52).
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*
Vaccines*
COVID-19/*prevention & control
Vaccination/*psychology
Adolescent ; Adult ; Aged ; Behavior ; Communication ; Female ; Humans ; Influenza Vaccines ; Intention ; Male ; Middle Aged ; Public Health ; SARS-CoV-2 ; Surveys and Questionnaires ; Trust ; United States ; Vaccination/ethics ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies